Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-15

FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Elite Laboratories, Inc.)

View source ↗

Summary

FDA approved the original application for lisdexamfetamine dimesylate as a generic product from Elite Laboratories, Inc., confirming regulatory clearance for sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)